In thyroid, prostate, colon, and breast cancer, Wnt5A is suggested to have a tumor-suppressor role wherein reconstitution of Wnt5A impairs tumor metastasis by targeting cell motility and, therefore, is associated with a higher disease-free survival [176]. This evidence concerns the gene WNT5A and neoplasm.